Kanay is an Associate at Forbion and joined the investment team in June 2025 in the Naarden office.
Prior to Forbion, Kanay was a Life Science Consultant at L.E.K. Consulting, where he led commercial due diligence and strategy engagements for global biopharma clients. He also gained experience in biotechnology investing at NB Capital and worked as an independent consultant for early-stage biotechnology companies.
Kanay holds a Medical Degree (MBBS) from Imperial College London, where he graduated with a Distinction in Clinical Sciences, as well as a BSc in Neuroscience and Mental Health. After completing medical school, he worked as a Resident Doctor in the Oxford University Hospitals NHS Trust.
